Chemours Co
NYSE:CC

Watchlist Manager
Chemours Co Logo
Chemours Co
NYSE:CC
Watchlist
Price: 22.1 USD 3.42%
Market Cap: $3.3B

Wall St Price Targets

CC Price Targets Summary
Chemours Co

Wall Street analysts forecast CC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CC is 27.41 USD with a low forecast of 21.21 USD and a high forecast of 31.5 USD.

Lowest Forecast
Price Target
21.21 USD
4% Downside
Average Forecast
Price Target
27.41 USD
24% Upside
Highest Forecast
Price Target
31.5 USD
43% Upside
Chemours Co Competitors:
Price Targets

Revenue
Forecast

-2% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
-2% / Year
Past Growth
6% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 6%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-20%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is CC's stock price target?
Price Target
27.41 USD

According to Wall Street analysts, the average 1-year price target for CC is 27.41 USD with a low forecast of 21.21 USD and a high forecast of 31.5 USD.

What is the Revenue forecast for Chemours Co?
Projected CAGR
6%

Over the last 13 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 3 years is 6%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett